公开(公告)号：US20180071479A1

公开(公告)日：2018-03-15

申请号：US15818290

申请日：2017-11-20

Applicant: AIRSONNET AB

Inventor： Dan Allan Robert KRISTENSSON ,  Pal Martin Svensson

IPC: A61M16/10 ,  F24F3/16 ,  A61G13/10 ,  A61M16/06 ,  A61M16/16 ,  A61M16/00 ,  A61H33/06 ,  A61H33/00 ,  A61H35/00

CPC classification number: A61M16/1075 ,  A61G13/108 ,  A61G2203/46 ,  A61H35/008 ,  A61H2033/0037 ,  A61H2033/062 ,  A61H2201/0107 ,  A61H2201/0169 ,  A61H2201/0207 ,  A61H2201/0214 ,  A61H2201/0228 ,  A61H2201/0242 ,  A61H2201/0285 ,  A61H2201/50 ,  A61H2201/5082 ,  A61H2203/0456 ,  A61M16/0066 ,  A61M16/06 ,  A61M16/0627 ,  A61M16/107 ,  A61M16/16 ,  A61M2205/3368 ,  A61M2205/3606 ,  A61M2205/3673 ,  F24F3/1607 ,  F24F2221/38

Abstract: The present invention provides a practical method for treating atopic dermatitis. By subjecting patients suffering from atopic dermatitis to filtered temperature controlled laminar air flow disease symptoms have been significantly reduced and even removed. The velocity of the laminar air flow is balanced such that body convections are braked without the generation of draught.